Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
At the center of the lawsuit is Teva Pharmaceutical, slated to sell a generic version of the HIV prevention pill PrEP next year.
Alisporivir, a once-daily drug being developed by Novartis at the forefront of a new class of hepatitis C virus (HCV) compounds known as cyclo...
Alisporivir, a once-daily drug at the forefront of a new class of hepatitis C virus (HCV) compounds known as cyclophilin inhibitors, significa...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.